Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Other Non Operating Income (2019 - 2026)

Biodesix filings provide 8 years of Other Non Operating Income readings, the most recent being $385000.0 for Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 292.86% to $385000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $891000.0, a 119.46% increase, with the full-year FY2025 number at $604000.0, up 727.4% from a year prior.
  • Other Non Operating Income hit $385000.0 in Q1 2026 for Biodesix, up from $46000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $409000.0 in Q3 2025 to a low of -$4.2 million in Q2 2022.
  • Median Other Non Operating Income over the past 5 years was $2000.0 (2023), compared with a mean of -$378588.2.
  • The widest YoY moves for Other Non Operating Income: up 18600.0% in 2024, down 38800.0% in 2024.
  • Biodesix's Other Non Operating Income stood at -$400000.0 in 2022, then soared by 100.5% to $2000.0 in 2023, then soared by 15950.0% to $321000.0 in 2024, then plummeted by 85.67% to $46000.0 in 2025, then skyrocketed by 736.96% to $385000.0 in 2026.
  • The last three reported values for Other Non Operating Income were $385000.0 (Q1 2026), $46000.0 (Q4 2025), and $409000.0 (Q3 2025) per Business Quant data.